Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

BACKGROUND: Higher serum phosphate and fibroblast growth factor-23 (FGF23) levels may be modifiable to prevent cardiovascular disease in CKD. Short-term studies have reported modest efficacy in phosphate and FGF23 reduction with intestinal phosphate binders in CKD. METHODS: To investigate effects of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Soc Nephrol
Main Authors: Ix, Joachim H., Isakova, Tamara, Larive, Brett, Raphael, Kalani L., Raj, Dominic S., Cheung, Alfred K., Sprague, Stuart M., Fried, Linda F., Gassman, Jennifer J., Middleton, John P., Flessner, Michael F., Block, Geoffrey A., Wolf, Myles
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2019
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551774/
https://ncbi.nlm.nih.gov/pubmed/31085679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101058
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki